Eprotirome

N/A

Report date: 2022/10/27 20:00:45
NME

Base Information

Drug NameEprotirome
Drug Alias Name伊泊替罗eprotiromum依普替罗eprotiromoKB-2115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsHeterozygous familial hypercholesterolemiaHypercholesterolemiaDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaro Bio Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaro Bio Ab
Active IndicationsN/A
Inactive IndicationsHeterozygous familial hypercholesterolemiaHypercholesterolemiaDyslipidemias

Other Information

ATC CodeN/A
Related LinksDrugBank